Skip to content

DR EGÜZ

Active Private limited companyfounded 2020active for 6 yearsRue du Progrès 9, 1410 WaterlooKBO/BCE: BE 0746.776.670

Lifetime

5 annual accounts with figures on one time axis
peak of €280,661 in 2025
€280,661▲ 8.9%
peak of €199,957 in 2025
€199,957▲ 7.6%
peak of €331,373 in 2023
€154,572▲ 64.2%
€191,638▼ 10.7%
Board1 name since 2020
1 director
Documentsfilings and deeds
20-08-202620 days late
2025micro format
Dividend €139,536Equity from €94,151 to €154,572

Key points

from the 2025 annual accounts

Equity

€154,572 from €331,373 in 2023

Equity fell by 53% in 2 years.

Turnover

≈ €420,000 estimated

The micro format states no turnover.

Liquidity

1.90 was 1.10 in 2024

Short-term debts fell from €214,390 to €153,440.

Filings

5 annual accounts 1 late
AprilJune31 JulyOctober20222024

The 2025 accounts came 20 days late. The other four were filed on time.

Position in the sector

€199,957

Higher net result than 88% of companies in human health. The sector median is €59,520, over 21,384 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as DR EGÜZ has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for DR EGÜZ. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 08-05-2020
  • chairdeed of 19-05-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0746776670
Registered office moved from Waterloo to Waterlo The registered office moved from Avenue des Sorbiers, 50 à 1410 Waterloo to rue du Progrès, 9 à 1410 Waterlo0 · holds all the shares · General meeting of 10-03-2023 · Gazette deed
Incorporation Founding capital of €4,000, 400 shares · Founded by · appointed as director · published on 12-05-2020 · Gazette deed
First establishment Rue du Progrès 9, Waterloo
All 13 events

Comparable companies

same main activity, similar in size and age
Company
DR EGÜZ Waterloo €346,210 €280,661 44.6% -
DOCTEUR Z. BOUTERFA Lasne €352,537 €308,661 1.5% -
DR MORTIER Lasne €398,593 €279,122 0.8% -
Dr. Bartel Thomas, Fysische geneeskunde en Revalidatie Sint-Martens-Latem €339,998 €305,739 81.9% -
Corbacor Kontich €371,814 €299,048 0.8% -
Dr H. NAIK Tervuren €374,710 €259,898 13.4% -
Charlotte De Bie MDL Antwerp €393,985 €277,652 8.9% -

These companies have the same main activity as DR EGÜZ: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €340,000 and €399,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 08-05-2020Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Establishment unit
2.302.381.5081410 Waterloo, since 08-05-2020
Financial year end
31 December
Peppol
Reachable since 17-01-2026
Company details

Annual accounts 2025

€346,210▲ 12.1%
Filing
Filed on 20-08-2026
Financials

Insights on DR EGÜZ

DR EGÜZ files the micro format. That format states no turnover. The gross margin rose from €145,715 in 2021 to €280,661 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR EGÜZ

What is the company number of DR EGÜZ?
The company number of DR EGÜZ is 0746.776.670. The VAT number is the same number with BE in front: BE 0746.776.670.
Where is DR EGÜZ based?
The registered office is at Rue du Progrès 9, 1410 Waterloo.Company details
What does DR EGÜZ do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR EGÜZ?
DR EGÜZ is a private limited company (BV).
When was DR EGÜZ founded?
DR EGÜZ was founded on 08-05-2020.
Is DR EGÜZ still active?
Yes, DR EGÜZ is an active enterprise in the KBO register.
What is the turnover of DR EGÜZ?
The turnover in financial year 2025 is about €420,000. This figure is estimated from the gross margin of €280,661 and 31 comparable companies (NACE 86220). It probably lies between €370,000 and €590,000.Financials
Is DR EGÜZ profitable?
In financial year 2025, DR EGÜZ made a profit of €199,957.
Where can I find the annual accounts of DR EGÜZ?
DR EGÜZ filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR EGÜZ due?
DR EGÜZ must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.